IBM's Memory-Chip Headache: When Hardware Demand Cannibalizes the Software Story
Published on 08/03/2026 at 04:21 | Redaktion boerse-global.de
The market's verdict on IBM has been brutal, but the company's problems may have less to do with its own execution than with a commodity IBM doesn't manufacture. A global shortage of memory chips has sent DRAM prices soaring by 100 to 116 percent in the first quarter of 2026, forcing enterprise customers to funnel their IT budgets into servers and storage — and defer the software upgrades, consulting engagements, and mainframe refreshes that form the backbone of IBM's most profitable business lines.
A Timing Problem, or Something Deeper?
The second quarter laid the weakness bare. Sales of Z-series mainframes collapsed by 42 percent, with CFO James Kavanaugh estimating the drag on overall growth at more than five percentage points. The company responded by trimming its 2026 outlook, now guiding for currency-adjusted revenue growth of 4 to 5 percent, down from a previous target of above 5 percent.
Management insists this is a timing issue rather than a structural one. Kavanaugh pushed back against any suggestion that customers are abandoning the mainframe platform, stating flatly that IBM sees no evidence of clients migrating away. CEO Arvind Krishna characterized the decline as largely temporary, noting that roughly one-third of the deferred deals had already closed in the third quarter.
The Software Engine Keeps Humming
Beneath the hardware turmoil, the software division continues to deliver. Segment revenue rose about 5.1 percent to $7.76 billion, with Red Hat — the hybrid-cloud crown jewel — posting an impressive 11 percent gain. Recurring annual revenue from OpenShift has reached $2.2 billion, and subscription-based income now accounts for roughly 80 percent of total software sales.
Should investors sell immediately? Or is it worth buying IBM?
This shift toward a recurring-revenue model is deliberate. The higher-margin software business is meant to cushion the cyclical swings in infrastructure, where product lifecycles and component shortages create inevitable volatility. For the remainder of 2026, IBM is leaning on its dividend policy and an anticipated $1 billion year-over-year increase in free cash flow to steady investor nerves.
A Stock Searching for a Floor
The share price tells a story of its own. IBM closed Friday at €194.74, up 1.31 percent on the day, but that modest bounce follows a punishing stretch. The stock sits roughly a third below its early-June high, has shed more than a fifth of its value over the past 30 days, and is down about 25 percent year to date. The 52-week low of €175.14, touched during a turbulent July, remains a fresh memory.
Technically, the picture suggests stabilization rather than reversal. The relative strength index at 41.2 indicates the stock has exited oversold territory, yet it hasn't built upward momentum. All major moving averages remain well above the current price — a bearish configuration — and the 16.24 percent gap below the 200-day average of €232.49 underscores how far the long-term trend has deteriorated. The 3.34 percent gain over the past week offers some comfort, but it follows a 22.52 percent slide over the prior month.
The Uncomfortable Dependency
Here's the crux: IBM's near-term fate hinges on a supply chain it doesn't control. If memory prices stay elevated — with AI data centers absorbing wafer capacity — enterprises could keep prioritizing hardware over software and services for several more quarters. That dynamic sits entirely outside management's influence.
The gap between the current price and the analyst consensus of €211.64 implies potential upside of 8.7 percent, but the market is pricing in genuine uncertainty about how long the "deferred, not destroyed" thesis will take to validate. With a market capitalization of €182.64 billion, IBM remains a company with substantial recurring software revenue. Investors, however, are unwilling to look past one or two more quarters of weak mainframe and infrastructure data.
IBM at a turning point? This analysis reveals what investors need to know now.
What to Watch Next
The coming weeks offer several signposts. Purchasing managers' indices for manufacturing and services could reveal whether corporate sentiment is cooling — particularly relevant given that IBM's consulting arm barely grew last quarter as clients redirected budgets toward AI hardware. US labor market data, including JOLTS job openings and the non-farm payrolls report, will provide a read on the broader business environment underpinning IBM's consulting pipeline. And investors continue to monitor how the company's AI order backlog, pegged at over $12 billion, converts into recognized revenue.
The decisive test, though, is simpler: Will the one-third of deferred deals that Krishna says already closed in the third quarter show up cleanly in the next earnings report? And will memory prices normalize enough for customers to resume spending across IBM's full portfolio rather than just on hardware? Until those questions are answered, IBM's stock looks less like a broken growth story and more like a bet on when a supply-chain bottleneck resolves itself — a wager the market is currently pricing with considerable skepticism.
Ad
IBM Stock: New Analysis - 3 August
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
